Moderna begins 3rd stage of trial for COVID-19 vaccine candidate mRNA-1273
Monday, July 27, 2020 - 08:00
in Health & Medicine
Drugmaker Moderna said Monday it has begun a 30,000-patient, third-stage clinical trial for its COVID-19 vaccine candidate -- a day after receiving an additional $472 million from the U.S. government.